Updated blood lead reference value for children

Dec. 2021Important Notices

The Centers for Disease Control and Prevention (CDC) recently updated its blood lead reference value (BLRV) from 5 µg/dL to 3.5 µg/dL in response to a recommendation by the Lead Exposure Prevention and Advisory Committee (LEPAC).

The BLRV aims to identify children with higher levels of lead in their blood compared to most children, based on the 97.5th percentile of the blood lead level (BLL) distribution in U.S. children ages 1 to 5 years.1 However, the CDC states that there is no safe BLL in children and that even low levels of lead in blood can affect learning and academic achievement and have permanent effects. It is critical for providers to partner with parents and caregivers to help prevent exposure and lower a child’s lead level, if necessary. To connect members with case management and for environmental lead investigation support, please contact the UPMC Pediatric Care Management Department. You can email a referral to pedscasemanagement@upmc.edu or call 1-866-778-6073 and select “pediatrics.”

Learn more
For more information about BLL in children, visit cdc.gov/nceh/lead/prevention/blood-lead-levels.htm. You can also view the UPMC Health Plan Lead Screening Provider Tip Sheet.

Source
1Centers for Disease Control and Prevention. CDC updates blood lead reference value for children. Last reviewed Oct. 28, 2021. Accessed Nov. 2, 2021. cdc.gov/media/releases/2021/p1028-blood-lead.html

Recent Announcements

Voluntary nationwide recall: True Metrix (Trividia – May)

Trividia Health is recalling all True Metrix Blood Glucose Systems for an issue with the software design of the E-5 Error Code and instructions for the user in the “Messages” section of the Owner’s Booklet/System instructions for use and online labeling and help guides.
May 2026Pharmacy Updates

Community Care Behavioral Health is excited to announce this free upcoming web-based training opportunity:

A growing body of U.S. and international research demonstrates that the rapid legalization and commercialization of gambling—including online casinos and mobile sports betting platforms—are associated with significant and escalating gambling related harm. Although Pennsylvania specific prevalence data remain limited, available evidence is increasingly concerning, with gambling disorder linked to alarmingly high rates of suicide, psychiatric comorbidity, and social and financial harm. Drawing on lessons from the tobacco and opioid crises, this presentation will examine how delayed recognition and regulation can amplify population level harm, underscoring the need for earlier screening, prevention, and policy engagement. Participants will gain practical guidance on identifying patients at elevated risk, implementing evidence informed screening and diagnostic strategies, and applying current treatment approaches across the lifespan.
May 2026Education/Webinars

Bridging Smiles and Systems: Collaborative Care for Children with Chronic Conditions

Please join us for a live, CME-accredited and CEU-accredited webinar on May 13 from noon to 1p.m., that will explore the critical connection between oral health and pediatric chronic conditions such as diabetes, asthma, congenital heart disease, and ADHD.
Apr. 2026Education/Webinars